Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 8/20 | 0.35 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 5/20 | 0.34 |
| ▸ | CES2 | O00748 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | PLOD2 | O00469 | 2/20 | 0.34 |
| ▸ | PLOD3 | O60568 | 1/20 | 0.33 |
| ▸ | PLOD1 | Q02809 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL197340 | 0.88 | MGAM (0.48) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL31364589 | 0.83 | MGAM (0.39) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL9468556 | 0.83 | TSHR (0.54) | TSHRHSD17B10FAAHCES1CES2 | |
| SCHEMBL9720470 | 0.83 | PLOD2 (0.43) | HSD17B10FAAHCES1CES2MEN1 | |
| SCHEMBL25223809 | 0.81 | GAA (0.54) | MGAMGAASIMGAM2HSD17B10 | |
| SCHEMBL3688748 | 0.81 | CA14 (0.35) | HSD17B10FAAHCES1CES2MEN1 | |
| SCHEMBL28100172 | 0.80 | MGAM (0.65) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL27976 | 0.80 | MGAM (0.61) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL6933557 | 0.79 | MGAM (0.44) | MGAMGAASIMGAM2TSHR | |
| SCHEMBL15688315 | 0.77 | MGAM (0.58) | MGAMGAASIMGAM2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7781601-B2 | Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters | BASEL (CH) | 2010-08-24 | — | — | US | disclosed |
| US-7781601-B2 | Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters | BASEL (CH) | 2010-08-24 | — | — | US | disclosed |
| US-7781601-B2 | Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters | BASEL (CH) | 2010-08-24 | — | — | US | disclosed |
| US-20080161582-A1 | Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters | HANSELMANN PAUL | 2008-07-03 | — | — | US | disclosed |
| US-20080161582-A1 | Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters | HANSELMANN PAUL | 2008-07-03 | — | — | US | disclosed |
| US-20080161582-A1 | Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters | HANSELMANN PAUL | 2008-07-03 | — | — | US | disclosed |
| US-7351851-B2 | Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters | LONZA AG (CH) | 2008-04-01 | — | — | US | disclosed |
| US-7351851-B2 | Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters | LONZA AG (CH) | 2008-04-01 | — | — | US | disclosed |
| US-7351851-B2 | Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters | LONZA AG (CH) | 2008-04-01 | — | — | US | disclosed |
| US-7348450-B2 | Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters | LONZA LTD. (CH) | 2008-03-25 | — | — | US | disclosed |
| US-7348450-B2 | Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters | LONZA LTD. (CH) | 2008-03-25 | — | — | US | disclosed |
| US-7348450-B2 | Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters | LONZA LTD. (CH) | 2008-03-25 | — | — | US | disclosed |
| US-20070083061-A1 | Method for the production of 6,6,6-tirhalo-3,5-dioxohexanoic acid esters | LONZA AG (CH) | 2007-04-12 | — | — | US | disclosed |
| US-20070083061-A1 | Method for the production of 6,6,6-tirhalo-3,5-dioxohexanoic acid esters | LONZA AG (CH) | 2007-04-12 | — | — | US | disclosed |
| US-20070083061-A1 | Method for the production of 6,6,6-tirhalo-3,5-dioxohexanoic acid esters | LONZA AG (CH) | 2007-04-12 | — | — | US | disclosed |
| US-20060235240-A1 | Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters | LONZA AG (CH) | 2006-10-19 | — | — | US | disclosed |
| EP-1680391-A1 | METHOD FOR THE PRODUCTION OF 6,6,6-TRIHALO-3,5-DIOXOHEXANOIC ACID ESTERS | LONZA AG (CH) | 2006-07-19 | — | — | EP | disclosed |
| WO-2005040087-A1 | METHOD FOR THE PRODUCTION OF 6,6,6-TRIHALO-3,5-DIOXOHEXANOIC ACID ESTERS | LONZA AG (CH) | 2005-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161582-A1 | Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters | ELOVL6, ACSL6, DAGLA | MGAM 1684/4885GAA 1005/4885SI 2542/4885 |
| US-20070083061-A1 | Method for the production of 6,6,6-tirhalo-3,5-dioxohexanoic acid esters | ELOVL6, DAGLA, ACSL6 | MGAM 1611/4885GAA 1239/4885SI 2291/4885 |
| US-20060235240-A1 | Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters | ELOVL6, ACSL6, DAGLA | MGAM 1684/4885GAA 1005/4885SI 2542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.